ESCITALOPRAM

ESCITALOPRAM was reported 142008 times

ESCITALOPRAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SPIROMETRY ABNORMAL 304 0.5084
1 MITE ALLERGY 288 0.4397
2 TOTAL LUNG CAPACITY ABNORMAL 145 0.3728
3 MYCOTIC ALLERGY 288 0.3368
4 PULMONARY VASCULITIS 171 0.3178
5 DUST ALLERGY 289 0.2946
6 AMAUROSIS FUGAX 245 0.2275
7 VITAL CAPACITY DECREASED 101 0.2254
8 CONJUNCTIVITIS ALLERGIC 311 0.2099
9 STEROID DEPENDENCE 181 0.2062
10 REVERSIBLE AIRWAYS OBSTRUCTION 102 0.2008
11 CATARRH 167 0.1847
12 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 115 0.1569
13 SPUTUM CULTURE POSITIVE 105 0.1293
14 PHYSICAL DECONDITIONING 308 0.1196
15 NEURITIS 177 0.1146
16 BURNS SECOND DEGREE 185 0.1054
17 NORMOCHROMIC NORMOCYTIC ANAEMIA 316 0.1051
18 BRONCHIAL SECRETION RETENTION 117 0.0918
19 SEROTONIN SYNDROME 1687 0.0877
20 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 172 0.0870
21 MAJOR DEPRESSION 635 0.0868
22 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 169 0.0828
23 SLEEP TALKING 114 0.0671
24 ALCOHOL POISONING 175 0.0653
25 RESPIRATORY SYMPTOM 183 0.0643
26 ANORGASMIA 164 0.0604
27 HYPOPNOEA 207 0.0596
28 GUN SHOT WOUND 109 0.0574
29 URINARY TRACT DISORDER 250 0.0555
30 ELECTRIC SHOCK SENSATION 154 0.0550
31 FORCED EXPIRATORY VOLUME DECREASED 155 0.0547
32 CLONUS 147 0.0537
33 SLEEP TERROR 219 0.0520
34 SEXUAL DYSFUNCTION 588 0.0501
35 HYPERREFLEXIA 173 0.0496
36 HYPERPARATHYROIDISM SECONDARY 123 0.0490
37 NEPHROGENIC ANAEMIA 219 0.0472
38 ARTERIOSCLEROSIS CORONARY ARTERY 311 0.0469
39 DEPRESSIVE SYMPTOM 164 0.0465
40 HAEMORRHAGIC STROKE 361 0.0462
41 TALIPES 143 0.0460
42 FLAT AFFECT 105 0.0453
43 SUSPECTED SUICIDE 212 0.0452
44 SMALL FOR DATES BABY 224 0.0451
45 FULL BLOOD COUNT ABNORMAL 475 0.0449
46 LONG QT SYNDROME 106 0.0442
47 HYPOMANIA 162 0.0440
48 MULTIPLE DRUG OVERDOSE INTENTIONAL 140 0.0435
49 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 219 0.0427
50 REBOUND ACID HYPERSECRETION 126 0.0416
51 SUICIDE ATTEMPT 2509 0.0413
52 PSYCHOMOTOR RETARDATION 115 0.0409
53 DIABETIC NEUROPATHY 201 0.0406
54 BLOOD PRESSURE DIASTOLIC ABNORMAL 101 0.0397
55 BRUXISM 211 0.0391
56 ARTERIOSCLEROSIS 368 0.0391
57 GAMBLING DISORDER 105 0.0388
58 NEUROLOGICAL SYMPTOM 222 0.0388
59 MANIA 629 0.0382
60 LOSS OF LIBIDO 342 0.0380
61 ANXIETY DISORDER 126 0.0377
62 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 387 0.0377
63 PRE-EXISTING CONDITION IMPROVED 235 0.0376
64 ALCOHOLISM 157 0.0366
65 SELF-INJURIOUS IDEATION 153 0.0364
66 CHOLECYSTITIS CHRONIC 243 0.0363
67 AKATHISIA 486 0.0356
68 SUICIDAL IDEATION 3257 0.0355
69 SUICIDAL BEHAVIOUR 147 0.0353
70 ELECTROCARDIOGRAM QT PROLONGED 1268 0.0352
71 FEELING OF DESPAIR 163 0.0349
72 TORSADE DE POINTES 273 0.0348
73 BIPOLAR DISORDER 373 0.0343
74 CARDIAC MURMUR 293 0.0338
75 OBSESSIVE-COMPULSIVE DISORDER 271 0.0337
76 ATRIAL SEPTAL DEFECT 282 0.0336
77 SOPOR 444 0.0335
78 TACHYPHRENIA 115 0.0332
79 POST-TRAUMATIC STRESS DISORDER 222 0.0331
80 PULMONARY ALVEOLAR HAEMORRHAGE 185 0.0329
81 HOMICIDAL IDEATION 133 0.0328
82 IMPULSIVE BEHAVIOUR 123 0.0327
83 GINGIVAL PAIN 260 0.0326
84 BRONCHIECTASIS 220 0.0326
85 PAROSMIA 246 0.0326
86 VENTRICULAR SEPTAL DEFECT 185 0.0323
87 OBSTRUCTIVE AIRWAYS DISORDER 359 0.0322
88 RHINITIS 254 0.0315
89 MATERNAL DRUGS AFFECTING FOETUS 241 0.0314
90 INTENTIONAL OVERDOSE 2000 0.0311
91 SOMNAMBULISM 204 0.0311
92 COLITIS MICROSCOPIC 147 0.0310
93 COMPLETED SUICIDE 2571 0.0308
94 INTENTIONAL SELF-INJURY 621 0.0307
95 PARANOIA 530 0.0307
96 PANIC DISORDER 119 0.0307
97 DECREASED INTEREST 181 0.0307
98 ALCOHOL USE 113 0.0306
99 BRADYKINESIA 178 0.0301
100 OCULAR DISCOMFORT 337 0.0300
101 PANIC ATTACK 1089 0.0298
102 MUSCLE RIGIDITY 357 0.0298
103 IMPAIRED QUALITY OF LIFE 426 0.0296
104 SNORING 112 0.0296
105 APATHY 429 0.0294
106 NODULE 379 0.0290
107 AFFECTIVE DISORDER 228 0.0290
108 DELUSION 446 0.0287
109 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 481 0.0283
110 POISONING DELIBERATE 267 0.0281
111 GESTATIONAL DIABETES 134 0.0281
112 GENERALISED OEDEMA 348 0.0281
113 SLEEP APNOEA SYNDROME 536 0.0281
114 ENURESIS 113 0.0279
115 HYPERTONIA 160 0.0279
116 PRODUCT ADMINISTRATION INTERRUPTED 218 0.0277
117 MYDRIASIS 356 0.0277
118 HALLUCINATION, AUDITORY 436 0.0274
119 DEPRESSION 6237 0.0274
120 MULTIPLE DRUG OVERDOSE 136 0.0274
121 CATATONIA 142 0.0270
122 TEARFULNESS 116 0.0269
123 BUNDLE BRANCH BLOCK LEFT 113 0.0266
124 SPINAL OSTEOARTHRITIS 234 0.0266
125 SOCIAL AVOIDANT BEHAVIOUR 154 0.0266
126 MULTIPLE ALLERGIES 207 0.0264
127 HALLUCINATIONS, MIXED 111 0.0264
128 INITIAL INSOMNIA 270 0.0263
129 POLYDIPSIA 104 0.0263
130 HYPERLIPIDAEMIA 314 0.0262
131 PANIC REACTION 187 0.0259
132 PARKINSONISM 252 0.0258
133 RESTLESS LEGS SYNDROME 468 0.0257
134 HEAD DISCOMFORT 454 0.0256
135 INTERVERTEBRAL DISC DEGENERATION 237 0.0256
136 ANHEDONIA 668 0.0254
137 UPPER-AIRWAY COUGH SYNDROME 209 0.0253
138 NEUROLEPTIC MALIGNANT SYNDROME 299 0.0252
139 SINUS BRADYCARDIA 243 0.0251
140 HYPERPHAGIA 100 0.0251
141 RED CELL DISTRIBUTION WIDTH INCREASED 104 0.0250
142 ORTHOSTATIC HYPOTENSION 428 0.0246
143 DRUG INTERACTION 3888 0.0245
144 TYPE 2 DIABETES MELLITUS 824 0.0245
145 MUSCLE TWITCHING 564 0.0244
146 RESTLESSNESS 891 0.0243
147 NIGHTMARE 838 0.0242
148 SWOLLEN TONGUE 754 0.0241
149 MYOCLONUS 287 0.0240
150 ALTERED STATE OF CONSCIOUSNESS 520 0.0240
151 HALLUCINATION, VISUAL 505 0.0239
152 BRADYPHRENIA 156 0.0239
153 DYSKINESIA 969 0.0238
154 ANXIETY 6785 0.0238
155 IMPAIRED WORK ABILITY 506 0.0236
156 HYPONATRAEMIA 1330 0.0236
157 AGITATION 1724 0.0235
158 ECONOMIC PROBLEM 354 0.0233
159 PSYCHOLOGICAL TRAUMA 199 0.0230
160 TINNITUS 1047 0.0228
161 OBESITY 363 0.0228
162 THINKING ABNORMAL 424 0.0227
163 BEHAVIOUR DISORDER 123 0.0227
164 SINUS TACHYCARDIA 322 0.0227
165 GLUCOSE TOLERANCE IMPAIRED 134 0.0226
166 PHOTOPHOBIA 425 0.0226
167 SEDATION 589 0.0225
168 TYPE 1 DIABETES MELLITUS 135 0.0224
169 COMA 1064 0.0223
170 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1063 0.0221
171 PRESYNCOPE 537 0.0221
172 IMPAIRED GASTRIC EMPTYING 300 0.0220
173 BUNDLE BRANCH BLOCK RIGHT 100 0.0218
174 WITHDRAWAL SYNDROME 913 0.0217
175 ELECTROCARDIOGRAM ABNORMAL 170 0.0216
176 CRYING 785 0.0216
177 ATELECTASIS 208 0.0215
178 VITAMIN D DEFICIENCY 209 0.0214
179 TENSION 130 0.0213
180 TRISMUS 110 0.0213
181 HYPERSOMNIA 609 0.0212
182 DISTURBANCE IN ATTENTION 1143 0.0212
183 GALACTORRHOEA 136 0.0212
184 DIPLOPIA 547 0.0210
185 VASCULITIS 245 0.0210
186 ABNORMAL DREAMS 580 0.0210
187 PSYCHOTIC DISORDER 615 0.0208
188 MENTAL DISORDER 905 0.0208
189 SOMNOLENCE 4148 0.0206
190 HAEMATEMESIS 522 0.0206
191 PSYCHOMOTOR HYPERACTIVITY 341 0.0205
192 CONCUSSION 158 0.0204
193 GRAND MAL CONVULSION 188 0.0203
194 ANGER 687 0.0203
195 OVERWEIGHT 109 0.0203
196 ERECTILE DYSFUNCTION 520 0.0202
197 HYPERTHERMIA 154 0.0202
198 TREMOR 3347 0.0201
199 DEPRESSED MOOD 1062 0.0201
200 END STAGE RENAL DISEASE 362 0.0198
201 POOR QUALITY SLEEP 423 0.0196
202 HALLUCINATION 1476 0.0196
203 ANAL INCONTINENCE 176 0.0195
204 TRICUSPID VALVE INCOMPETENCE 155 0.0195
205 FEELING JITTERY 371 0.0194
206 MITRAL VALVE INCOMPETENCE 220 0.0194
207 PSYCHIATRIC SYMPTOM 143 0.0194
208 TUBULOINTERSTITIAL NEPHRITIS 362 0.0193
209 CARDIO-RESPIRATORY ARREST 805 0.0192
210 URINARY INCONTINENCE 568 0.0192
211 SCREAMING 122 0.0191
212 METABOLIC ACIDOSIS 612 0.0191
213 MENTAL STATUS CHANGES 529 0.0190
214 MIDDLE INSOMNIA 355 0.0190
215 PERSONALITY CHANGE 176 0.0189
216 COGNITIVE DISORDER 883 0.0189
217 DISSOCIATION 144 0.0188
218 ABNORMAL BEHAVIOUR 739 0.0186
219 HEAD INJURY 589 0.0186
220 HYPOXIA 655 0.0186
221 ECCHYMOSIS 127 0.0185
222 INTERVERTEBRAL DISC PROTRUSION 404 0.0185
223 EOSINOPHIL COUNT INCREASED 154 0.0185
224 DRUG SCREEN POSITIVE 146 0.0185
225 AGGRESSION 921 0.0184
226 PULMONARY EMBOLISM 1744 0.0183
227 CHRONIC KIDNEY DISEASE 1394 0.0183
228 CONFUSIONAL STATE 2965 0.0183
229 HYPOMAGNESAEMIA 255 0.0183
230 ENERGY INCREASED 108 0.0183
231 HYPOVOLAEMIA 107 0.0183
232 INCONTINENCE 193 0.0182
233 HYPOTONIA 182 0.0182
234 SEASONAL ALLERGY 258 0.0182
235 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 110 0.0181
236 ON AND OFF PHENOMENON 100 0.0180
237 BRAIN FOG 282 0.0180
238 HIATUS HERNIA 232 0.0179
239 WALKING AID USER 118 0.0179
240 IRRITABILITY 1075 0.0179
241 EUPHORIC MOOD 183 0.0178
242 RIB FRACTURE 366 0.0178
243 TROPONIN INCREASED 135 0.0177
244 MENTAL IMPAIRMENT 429 0.0177
245 SLEEP DISORDER 1242 0.0176
246 FEAR 473 0.0176
247 HEPATIC STEATOSIS 327 0.0175
248 INFUSION SITE SWELLING 110 0.0175
249 AMNESIA 1137 0.0175
250 BLOOD TRIGLYCERIDES INCREASED 308 0.0174
251 LIGAMENT SPRAIN 172 0.0174
252 BALANCE DISORDER 1503 0.0174
253 COORDINATION ABNORMAL 242 0.0173
254 PRODUCT SUBSTITUTION ISSUE 996 0.0173
255 INCREASED APPETITE 330 0.0173
256 HYPOKINESIA 250 0.0172
257 CARDIOGENIC SHOCK 247 0.0172
258 HYPOTHYROIDISM 549 0.0172
259 TACHYCARDIA 1527 0.0172
260 INCOHERENT 111 0.0171
261 BLOOD MAGNESIUM DECREASED 148 0.0171
262 INSOMNIA 4555 0.0171
263 DEEP VEIN THROMBOSIS 1111 0.0171
264 FEELING DRUNK 127 0.0171
265 FALL 5673 0.0170
266 VITAMIN D DECREASED 145 0.0169
267 DISORIENTATION 670 0.0169
268 CONGENITAL ANOMALY 130 0.0168
269 PRODUCTIVE COUGH 799 0.0167
270 DIZZINESS POSTURAL 162 0.0167
271 CONVULSION 955 0.0167
272 VENTRICULAR EXTRASYSTOLES 173 0.0166
273 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 147 0.0166
274 LETHARGY 956 0.0166
275 HYPERHIDROSIS 2140 0.0166
276 WRIST FRACTURE 198 0.0165
277 EMOTIONAL DISORDER 509 0.0165
278 PULMONARY MASS 245 0.0164
279 OSTEOPENIA 249 0.0164
280 FOOT FRACTURE 311 0.0164
281 DROOLING 113 0.0163
282 HYPOKALAEMIA 753 0.0163
283 BRAIN INJURY 163 0.0162
284 RESPIRATORY TRACT INFECTION 423 0.0162
285 CEREBRAL DISORDER 120 0.0162
286 TARDIVE DYSKINESIA 456 0.0161
287 DECREASED ACTIVITY 174 0.0161
288 DEPRESSED LEVEL OF CONSCIOUSNESS 638 0.0161
289 NIGHT SWEATS 519 0.0161
290 BLOOD SODIUM DECREASED 301 0.0160
291 WEIGHT FLUCTUATION 167 0.0159
292 EYE MOVEMENT DISORDER 109 0.0159
293 DELIRIUM 551 0.0159
294 DIABETES MELLITUS 1207 0.0158
295 FORMICATION 110 0.0158
296 DYSGRAPHIA 104 0.0158
297 TOOTH FRACTURE 174 0.0158
298 REFUSAL OF TREATMENT BY PATIENT 103 0.0158
299 BLOOD POTASSIUM DECREASED 474 0.0157
300 POLYURIA 129 0.0157
301 DYSARTHRIA 593 0.0157
302 VERTIGO 959 0.0157
303 SKIN LACERATION 171 0.0157
304 GALLBLADDER DISORDER 279 0.0156
305 MOOD SWINGS 498 0.0156
306 CARDIOMEGALY 192 0.0156
307 DECUBITUS ULCER 127 0.0156
308 MUSCLE SPASTICITY 191 0.0155
309 INCREASED TENDENCY TO BRUISE 143 0.0155
310 PULMONARY FIBROSIS 298 0.0155
311 BLOOD ALBUMIN DECREASED 123 0.0155
312 URINARY RETENTION 517 0.0155
313 AFFECT LABILITY 149 0.0155
314 DENTAL CARIES 171 0.0154
315 POLYP 101 0.0154
316 CHOLELITHIASIS 505 0.0154
317 MIGRAINE 1469 0.0154
318 HAEMATOCRIT DECREASED 305 0.0154
319 BREAST MASS 103 0.0153
320 DYSTONIA 297 0.0153
321 INFUSION SITE ERYTHEMA 129 0.0153
322 SYNCOPE 1528 0.0153
323 DEMENTIA 425 0.0152
324 BEDRIDDEN 199 0.0151
325 VENTRICULAR FIBRILLATION 168 0.0151
326 GENERALISED TONIC-CLONIC SEIZURE 250 0.0151
327 ASCITES 444 0.0151
328 FREQUENT BOWEL MOVEMENTS 408 0.0151
329 HAEMODYNAMIC INSTABILITY 115 0.0151
330 JOINT EFFUSION 104 0.0151
331 EYE PAIN 851 0.0151
332 WEIGHT INCREASED 3370 0.0150
333 IMPAIRED DRIVING ABILITY 171 0.0150
334 NERVOUSNESS 786 0.0150
335 RENAL CYST 119 0.0150
336 APHASIA 452 0.0150
337 HAND FRACTURE 106 0.0149
338 OSTEOARTHRITIS 633 0.0149
339 APNOEA 116 0.0149
340 BLOOD PRESSURE SYSTOLIC INCREASED 290 0.0149
341 DIABETES MELLITUS INADEQUATE CONTROL 263 0.0148
342 CARPAL TUNNEL SYNDROME 208 0.0148
343 MALNUTRITION 166 0.0148
344 ATAXIA 176 0.0148
345 FLANK PAIN 139 0.0148
346 MIOSIS 119 0.0148
347 GASTROOESOPHAGEAL REFLUX DISEASE 1193 0.0148
348 CLOSTRIDIUM DIFFICILE COLITIS 157 0.0148
349 HAIR DISORDER 122 0.0148
350 HAEMOPTYSIS 410 0.0147
351 UNRESPONSIVE TO STIMULI 379 0.0147
352 MUSCULOSKELETAL CHEST PAIN 227 0.0147
353 BLOOD CHOLESTEROL INCREASED 683 0.0146
354 ACTIVITIES OF DAILY LIVING IMPAIRED 288 0.0145
355 HEREDITARY ANGIOEDEMA 156 0.0145
356 BRONCHITIS 1076 0.0145
357 HAEMATURIA 497 0.0145
358 FOETAL EXPOSURE DURING PREGNANCY 1179 0.0145
359 MUSCLE TIGHTNESS 234 0.0144
360 ARTHROPOD BITE 107 0.0144
361 ANKLE FRACTURE 222 0.0143
362 POISONING 180 0.0143
363 BLOOD IRON DECREASED 170 0.0143
364 DRUG TOXICITY 195 0.0143
365 WHEEZING 848 0.0143
366 NECK PAIN 798 0.0143
367 LOSS OF CONSCIOUSNESS 1828 0.0143
368 RECTAL HAEMORRHAGE 611 0.0142
369 RETCHING 303 0.0142
370 SALIVARY HYPERSECRETION 142 0.0142
371 MEMORY IMPAIRMENT 1950 0.0142
372 FIBROMYALGIA 345 0.0142
373 CHOLECYSTITIS 169 0.0142
374 NOCTURIA 172 0.0142
375 PREGNANCY 283 0.0141
376 MYOPATHY 122 0.0141
377 CHOLECYSTECTOMY 161 0.0141
378 UTERINE LEIOMYOMA 103 0.0141
379 QUALITY OF LIFE DECREASED 189 0.0141
380 IRON DEFICIENCY ANAEMIA 130 0.0141
381 HAIR TEXTURE ABNORMAL 188 0.0140
382 RENAL FAILURE CHRONIC 108 0.0140
383 MOOD ALTERED 383 0.0140
384 PALPITATIONS 1644 0.0140
385 MOTOR DYSFUNCTION 143 0.0140
386 NERVE COMPRESSION 129 0.0140
387 ACUTE RESPIRATORY FAILURE 268 0.0139
388 HUNGER 194 0.0139
389 SENSORY LOSS 112 0.0139
390 INFUSION SITE PAIN 179 0.0139
391 FACIAL PAIN 124 0.0139
392 THIRST 248 0.0139
393 BODY TEMPERATURE INCREASED 283 0.0139
394 CAESAREAN SECTION 161 0.0138
395 CONDITION AGGRAVATED 4199 0.0138
396 BLADDER DISORDER 137 0.0138
397 PRESCRIBED OVERDOSE 266 0.0137
398 SPEECH DISORDER 719 0.0137
399 DEHYDRATION 1829 0.0137
400 BLOOD CALCIUM DECREASED 154 0.0137
401 HAEMATOMA 353 0.0136
402 LACERATION 128 0.0136
403 RED BLOOD CELL COUNT DECREASED 388 0.0136
404 EXTRAPYRAMIDAL DISORDER 336 0.0135
405 URINARY TRACT INFECTION 2303 0.0135
406 DRY MOUTH 1095 0.0135
407 BRADYCARDIA 715 0.0135
408 FEELING ABNORMAL 3225 0.0134
409 TOOTHACHE 243 0.0134
410 MICTURITION URGENCY 153 0.0134
411 EXOSTOSIS 122 0.0133
412 ROTATOR CUFF SYNDROME 171 0.0133
413 DRUG WITHDRAWAL SYNDROME NEONATAL 197 0.0133
414 INSURANCE ISSUE 203 0.0133
415 ACUTE KIDNEY INJURY 2029 0.0132
416 TENDERNESS 138 0.0132
417 INJURY 928 0.0132
418 POLLAKIURIA 550 0.0132
419 DYSPHONIA 771 0.0132
420 ROAD TRAFFIC ACCIDENT 551 0.0132
421 NEURALGIA 320 0.0131
422 IRRITABLE BOWEL SYNDROME 282 0.0131
423 HAIR COLOUR CHANGES 163 0.0131
424 ELECTROLYTE IMBALANCE 152 0.0131
425 CONTUSION 1257 0.0130
426 DRUG LEVEL INCREASED 216 0.0130
427 LYMPHOCYTE COUNT DECREASED 230 0.0130
428 HAEMORRHOIDS 253 0.0130
429 EAR DISCOMFORT 133 0.0129
430 BONE DISORDER 236 0.0129
431 SCIATICA 206 0.0129
432 DIZZINESS 6431 0.0129
433 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 672 0.0129
434 UPPER RESPIRATORY TRACT INFECTION 593 0.0128
435 THERAPY CHANGE 126 0.0128
436 BLOOD PRESSURE FLUCTUATION 306 0.0127
437 GASTROENTERITIS VIRAL 230 0.0127
438 OXYGEN SATURATION DECREASED 711 0.0126
439 SENSORY DISTURBANCE 203 0.0126
440 COELIAC DISEASE 124 0.0126
441 HYPERCHOLESTEROLAEMIA 122 0.0126
442 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 898 0.0126
443 BLINDNESS 514 0.0126
444 BURSITIS 153 0.0126
445 TOXICITY TO VARIOUS AGENTS 2115 0.0125
446 ENCEPHALOPATHY 308 0.0125
447 COLD SWEAT 221 0.0125
448 VENTRICULAR TACHYCARDIA 207 0.0125
449 ACCIDENTAL OVERDOSE 458 0.0125
450 OVARIAN CYST 125 0.0125
451 DYSPNOEA EXERTIONAL 471 0.0125
452 SUBDURAL HAEMATOMA 179 0.0125
453 ANOREXIA 161 0.0125
454 RHABDOMYOLYSIS 521 0.0125
455 FATIGUE 9701 0.0124
456 HOSPICE CARE 123 0.0124
457 TREATMENT NONCOMPLIANCE 681 0.0124
458 SUPRAVENTRICULAR TACHYCARDIA 119 0.0124
459 HYPERAESTHESIA 102 0.0124
460 NERVE INJURY 138 0.0124
461 SINUSITIS 1272 0.0124
462 ARTHRITIS 975 0.0124
463 DYSURIA 456 0.0124
464 SCAR 212 0.0124
465 HOT FLUSH 933 0.0124
466 BLOOD ALKALINE PHOSPHATASE INCREASED 307 0.0123
467 BLOOD PRESSURE INCREASED 1890 0.0123
468 SINUS CONGESTION 167 0.0123
469 EAR PAIN 240 0.0123
470 BLOOD COUNT ABNORMAL 187 0.0123
471 BACK INJURY 134 0.0123
472 DYSGEUSIA 914 0.0123
473 DECREASED APPETITE 2855 0.0123
474 PANCREATITIS 649 0.0123
475 HEART RATE DECREASED 431 0.0123
476 PARAESTHESIA 1929 0.0122
477 SEIZURE 1416 0.0122
478 CHILLS 1433 0.0122
479 GASTRITIS 321 0.0122
480 UPPER LIMB FRACTURE 243 0.0122
481 WEIGHT DECREASED 3404 0.0122
482 NAUSEA 9643 0.0122
483 SWELLING FACE 792 0.0122
484 SLUGGISHNESS 124 0.0121
485 HAEMATOCHEZIA 670 0.0121
486 MEDICATION ERROR 674 0.0121
487 LUNG INFILTRATION 107 0.0121
488 HIP FRACTURE 389 0.0121
489 PNEUMONIA ASPIRATION 302 0.0121
490 RESPIRATORY RATE INCREASED 107 0.0120
491 HEMIPARESIS 204 0.0120
492 LIMB INJURY 327 0.0120
493 THROMBOSIS 968 0.0120
494 MOVEMENT DISORDER 386 0.0120
495 HYPOPHAGIA 307 0.0120
496 HEADACHE 7526 0.0120
497 ASTHENIA 4508 0.0120
498 BODY TEMPERATURE DECREASED 118 0.0120
499 RENAL INJURY 356 0.0120
500 KIDNEY INFECTION 235 0.0120
501 STATUS EPILEPTICUS 135 0.0119
502 GASTRIC ULCER 227 0.0119
503 PHARYNGITIS 148 0.0119
504 GAIT DISTURBANCE 2283 0.0119
505 VITREOUS FLOATERS 117 0.0119
506 SMALL INTESTINAL OBSTRUCTION 146 0.0118
507 ABDOMINAL PAIN 2759 0.0118
508 VISION BLURRED 1625 0.0118
509 TOOTH INFECTION 156 0.0118
510 RESPIRATORY ARREST 326 0.0118
511 SINUS DISORDER 234 0.0118
512 DISEASE RECURRENCE 561 0.0118
513 HYPOTENSION 2364 0.0118
514 DYSSTASIA 344 0.0118
515 WHITE BLOOD CELL COUNT INCREASED 451 0.0117
516 BACK DISORDER 191 0.0117
517 BODY HEIGHT DECREASED 125 0.0117
518 MUSCULOSKELETAL DISCOMFORT 201 0.0117
519 CONSTIPATION 2544 0.0117
520 NEPHROLITHIASIS 534 0.0116
521 HYPOAESTHESIA 1742 0.0116
522 TEMPERATURE INTOLERANCE 120 0.0116
523 PAIN IN JAW 329 0.0116
524 EATING DISORDER 247 0.0116
525 SPUTUM DISCOLOURED 110 0.0116
526 MUSCULAR WEAKNESS 1314 0.0116
527 FLUSHING 1174 0.0115
528 CANDIDA INFECTION 195 0.0115
529 HEART RATE INCREASED 1144 0.0115
530 JOINT DISLOCATION 122 0.0115
531 UPPER GASTROINTESTINAL HAEMORRHAGE 194 0.0115
532 FEELING HOT 706 0.0115
533 LEUKOCYTOSIS 208 0.0115
534 PULMONARY THROMBOSIS 125 0.0115
535 BLOOD POTASSIUM INCREASED 186 0.0114
536 VOMITING 5383 0.0114
537 PELVIC PAIN 208 0.0114
538 ASTHMA 1294 0.0114
539 OESOPHAGITIS 125 0.0114
540 CYSTITIS 364 0.0114
541 ANGIOEDEMA 504 0.0114
542 DYSPHAGIA 1077 0.0113
543 HEAVY MENSTRUAL BLEEDING 102 0.0113
544 HYPOCALCAEMIA 214 0.0113
545 HYPERGLYCAEMIA 411 0.0113
546 MUSCULOSKELETAL STIFFNESS 986 0.0112
547 BREAST PAIN 120 0.0112
548 PANCREATITIS ACUTE 252 0.0112
549 DERMATITIS ALLERGIC 141 0.0112
550 OEDEMA PERIPHERAL 1363 0.0112
551 THERAPEUTIC RESPONSE UNEXPECTED 501 0.0112
552 PULMONARY CONGESTION 147 0.0111
553 PHARYNGEAL SWELLING 109 0.0111
554 ASPIRATION 122 0.0111
555 DERMATITIS CONTACT 127 0.0111
556 NASAL CONGESTION 653 0.0111
557 DIARRHOEA 7172 0.0111
558 PHARYNGITIS STREPTOCOCCAL 120 0.0111
559 ABDOMINAL PAIN UPPER 2282 0.0111
560 COVID-19 1941 0.0111
561 GAMMA-GLUTAMYLTRANSFERASE INCREASED 245 0.0110
562 BLOOD CREATINE PHOSPHOKINASE INCREASED 318 0.0110
563 ORAL PAIN 247 0.0110
564 MULTIPLE SCLEROSIS RELAPSE 754 0.0110
565 SPINAL DISORDER 104 0.0110
566 FEELING COLD 305 0.0109
567 ABDOMINAL DISCOMFORT 1835 0.0109
568 DYSPEPSIA 1074 0.0109
569 THERAPY CESSATION 560 0.0109
570 SCRATCH 115 0.0109
571 RENAL FAILURE 1442 0.0108
572 MADAROSIS 126 0.0108
573 NEUTROPHIL COUNT INCREASED 111 0.0108
574 MULTIPLE SCLEROSIS 518 0.0108
575 GASTROINTESTINAL PAIN 119 0.0108
576 ALANINE AMINOTRANSFERASE INCREASED 664 0.0108
577 JOINT INJURY 231 0.0108
578 THERAPY NON-RESPONDER 486 0.0108
579 MYALGIA 1837 0.0108
580 HYPOGLYCAEMIA 524 0.0108
581 INTERNATIONAL NORMALISED RATIO INCREASED 308 0.0108
582 OSTEOPOROSIS 444 0.0108
583 INABILITY TO AFFORD MEDICATION 107 0.0108
584 RESPIRATORY TRACT CONGESTION 171 0.0108
585 CHEST PAIN 1993 0.0107
586 INTENTIONAL DOSE OMISSION 306 0.0107
587 SKIN HAEMORRHAGE 159 0.0107
588 BACK PAIN 2492 0.0107
589 EAR INFECTION 285 0.0107
590 TOOTH ABSCESS 109 0.0107
591 HYPERTENSION 2265 0.0107
592 DRUG ABUSE 890 0.0107
593 CARDIAC ARREST 882 0.0107
594 INTENTIONAL PRODUCT USE ISSUE 935 0.0107
595 STAPHYLOCOCCAL INFECTION 352 0.0107
596 TRANSIENT ISCHAEMIC ATTACK 360 0.0107
597 PRODUCT DOSE OMISSION IN ERROR 302 0.0107
598 ECZEMA 558 0.0107
599 COLITIS ULCERATIVE 476 0.0106
600 INFLUENZA LIKE ILLNESS 874 0.0106
601 DIVERTICULITIS 294 0.0106
602 RESPIRATORY DEPRESSION 130 0.0106
603 SUBARACHNOID HAEMORRHAGE 108 0.0106
604 ASPARTATE AMINOTRANSFERASE INCREASED 563 0.0106
605 COUGH 2971 0.0106
606 MUSCULOSKELETAL PAIN 555 0.0106
607 ARRHYTHMIA 501 0.0106
608 CELLULITIS 532 0.0105
609 CENTRAL NERVOUS SYSTEM LESION 145 0.0105
610 CLOSTRIDIUM DIFFICILE INFECTION 230 0.0105
611 LUNG DISORDER 516 0.0105
612 THYROID DISORDER 162 0.0105
613 CHOKING 205 0.0105
614 PAIN IN EXTREMITY 3093 0.0105
615 GASTROENTERITIS 153 0.0105
616 BLOOD UREA INCREASED 175 0.0104
617 POOR VENOUS ACCESS 108 0.0104
618 EPILEPSY 319 0.0104
619 OROPHARYNGEAL PAIN 966 0.0104
620 SCAB 119 0.0104
621 PRESCRIBED UNDERDOSE 208 0.0104
622 MUSCLE SPASMS 1912 0.0104
623 SPLENOMEGALY 122 0.0104
624 EMPHYSEMA 105 0.0104
625 EYE DISCHARGE 108 0.0104
626 MOUTH ULCERATION 219 0.0104
627 PULMONARY HYPERTENSION 216 0.0104
628 MYOCARDIAL ISCHAEMIA 118 0.0104
629 HEART RATE IRREGULAR 234 0.0103
630 RED BLOOD CELL SEDIMENTATION RATE INCREASED 114 0.0103
631 PLATELET COUNT INCREASED 134 0.0103
632 DISCOMFORT 626 0.0102
633 DIABETIC KETOACIDOSIS 246 0.0102
634 FLATULENCE 579 0.0102
635 POST PROCEDURAL COMPLICATION 196 0.0102
636 RENAL TUBULAR NECROSIS 100 0.0102
637 GAIT INABILITY 340 0.0102
638 DISABILITY 201 0.0102
639 SPINAL PAIN 119 0.0101
640 CHEST DISCOMFORT 1035 0.0101
641 NERVOUS SYSTEM DISORDER 315 0.0101
642 CARDIOMYOPATHY 149 0.0101
643 NEUROPATHY PERIPHERAL 951 0.0100
644 ATRIAL FIBRILLATION 973 0.0100
645 ABSCESS 159 0.0100
646 BLOOD PRESSURE ABNORMAL 197 0.0099
647 UNEVALUABLE EVENT 749 0.0099
648 MOBILITY DECREASED 711 0.0099
649 SKIN INFECTION 111 0.0099
650 DYSPNOEA 5596 0.0099
651 CORONARY ARTERY DISEASE 298 0.0098
652 INFLUENZA 1096 0.0098
653 LIMB DISCOMFORT 304 0.0098
654 VIRAL INFECTION 326 0.0098
655 PLEURAL EFFUSION 596 0.0098
656 DRUG INTOLERANCE 946 0.0098
657 BLOOD PRESSURE DECREASED 650 0.0098
658 FUNGAL INFECTION 326 0.0098
659 MENORRHAGIA 192 0.0098
660 PROCEDURAL PAIN 271 0.0098
661 RHINORRHOEA 630 0.0097
662 OSTEOMYELITIS 176 0.0097
663 ACCIDENT 116 0.0097
664 FEEDING DISORDER 197 0.0097
665 SCHIZOPHRENIA 118 0.0097
666 SEPSIS 1082 0.0097
667 GOUT 174 0.0097
668 ORAL HERPES 189 0.0097
669 GASTRIC DISORDER 332 0.0097
670 ABDOMINAL PAIN LOWER 244 0.0096
671 HERPES ZOSTER 554 0.0096
672 BLOOD URINE PRESENT 183 0.0096
673 AMENORRHOEA 169 0.0096
674 DEVICE DISLOCATION 419 0.0096
675 PREMATURE BABY 290 0.0096
676 LYMPHADENOPATHY 341 0.0096
677 BURNING SENSATION 674 0.0096
678 PAIN 5903 0.0096
679 ABDOMINAL DISTENSION 1003 0.0096
680 DRY EYE 479 0.0096
681 CHOLESTASIS 184 0.0096
682 HERNIA 185 0.0096
683 GLAUCOMA 184 0.0095
684 MUSCLE ATROPHY 121 0.0095
685 EMOTIONAL DISTRESS 1155 0.0095
686 ANAEMIA 1818 0.0095
687 ARTHRALGIA 3961 0.0095
688 DYSMENORRHOEA 126 0.0095
689 ORAL CANDIDIASIS 125 0.0095
690 TOOTH DISORDER 211 0.0095
691 HYPOAESTHESIA ORAL 143 0.0095
692 CORONARY ARTERY OCCLUSION 130 0.0095
693 PNEUMONIA 3067 0.0095
694 ABASIA 234 0.0095
695 GINGIVAL BLEEDING 129 0.0094
696 GASTROINTESTINAL DISORDER 846 0.0094
697 DRUG EXPOSURE DURING PREGNANCY 321 0.0094
698 MYOCARDITIS 108 0.0094
699 GENERAL PHYSICAL HEALTH DETERIORATION 1090 0.0094
700 LOWER LIMB FRACTURE 181 0.0094
701 ISCHAEMIC STROKE 168 0.0094
702 BLOOD BILIRUBIN INCREASED 254 0.0094
703 PRODUCT ADMINISTRATION ERROR 190 0.0094
704 SURGERY 551 0.0094
705 PERIPHERAL COLDNESS 129 0.0094
706 PERICARDIAL EFFUSION 217 0.0094
707 TENDONITIS 145 0.0094
708 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 513 0.0093
709 RENAL FAILURE ACUTE 396 0.0093
710 PRODUCT DOSE OMISSION 608 0.0093
711 MALAISE 4081 0.0093
712 SHOCK 214 0.0093
713 SPINAL FRACTURE 186 0.0093
714 HAEMOGLOBIN DECREASED 951 0.0093
715 SKIN LESION 254 0.0093
716 COAGULOPATHY 154 0.0092
717 GLOMERULAR FILTRATION RATE DECREASED 113 0.0092
718 CEREBRAL HAEMORRHAGE 329 0.0092
719 BRAIN OEDEMA 116 0.0092
720 PARAESTHESIA ORAL 132 0.0091
721 OVERDOSE 1971 0.0091
722 PHARYNGEAL OEDEMA 140 0.0091
723 DRUG WITHDRAWAL SYNDROME 797 0.0091
724 NASOPHARYNGITIS 1673 0.0091
725 SYSTEMIC LUPUS ERYTHEMATOSUS 322 0.0091
726 LIVER FUNCTION TEST INCREASED 194 0.0090
727 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 232 0.0090
728 HYPERKALAEMIA 316 0.0090
729 PRODUCT AVAILABILITY ISSUE 205 0.0090
730 PALLOR 245 0.0090
731 OEDEMA 488 0.0090
732 CARDIAC FAILURE CONGESTIVE 722 0.0090
733 RESPIRATORY DISTRESS 248 0.0090
734 RASH PRURITIC 485 0.0089
735 JOINT STIFFNESS 234 0.0089
736 FAECES DISCOLOURED 193 0.0089
737 ILLNESS 916 0.0089
738 SECRETION DISCHARGE 111 0.0089
739 PYREXIA 3062 0.0088
740 BASAL CELL CARCINOMA 138 0.0088
741 CYANOSIS 139 0.0088
742 EJECTION FRACTION DECREASED 137 0.0088
743 ADVERSE DRUG REACTION 791 0.0088
744 LIVER FUNCTION TEST ABNORMAL 256 0.0088
745 BONE PAIN 515 0.0088
746 PULMONARY OEDEMA 393 0.0088
747 PRODUCT PRESCRIBING ERROR 209 0.0088
748 FLUID RETENTION 446 0.0088
749 SPINAL OPERATION 108 0.0088
750 WHITE BLOOD CELL COUNT DECREASED 950 0.0088
751 CIRCULATORY COLLAPSE 149 0.0087
752 HEPATOCELLULAR INJURY 124 0.0087
753 PHOTOSENSITIVITY REACTION 143 0.0087
754 WOUND 242 0.0086
755 ADRENAL INSUFFICIENCY 105 0.0086
756 SKIN FISSURES 169 0.0086
757 FULL BLOOD COUNT DECREASED 174 0.0086
758 EPISTAXIS 645 0.0086
759 CYST 107 0.0086
760 BACTERAEMIA 102 0.0086
761 PRURITUS 3284 0.0085
762 PRODUCT USE IN UNAPPROVED INDICATION 2117 0.0085
763 ALOPECIA 1676 0.0085
764 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 146 0.0085
765 AGRANULOCYTOSIS 158 0.0085
766 JOINT RANGE OF MOTION DECREASED 114 0.0085
767 SARS-COV-2 TEST POSITIVE 112 0.0085
768 SKIN ULCER 218 0.0084
769 THROAT TIGHTNESS 228 0.0084
770 PERIPHERAL SWELLING 1298 0.0084
771 HEPATIC CIRRHOSIS 158 0.0084
772 DERMATITIS ATOPIC 443 0.0084
773 SKIN DISORDER 280 0.0084
774 IMPAIRED HEALING 275 0.0084
775 RESPIRATORY FAILURE 610 0.0084
776 MELAENA 183 0.0083
777 WRONG TECHNIQUE IN DRUG USAGE PROCESS 302 0.0083
778 LOCALISED INFECTION 201 0.0083
779 RASH MACULAR 290 0.0083
780 PRURITUS GENERALISED 179 0.0083
781 HYPERSENSITIVITY 1535 0.0083
782 DEAFNESS 216 0.0083
783 THROAT IRRITATION 370 0.0082
784 DRUG ERUPTION 146 0.0082
785 TACHYPNOEA 112 0.0082
786 TASTE DISORDER 166 0.0082
787 STOMATITIS 496 0.0082
788 EYE SWELLING 304 0.0082
789 ULCER 130 0.0082
790 MASS 114 0.0081
791 HYPERTHYROIDISM 118 0.0081
792 BACTERIAL INFECTION 152 0.0081
793 MUSCULOSKELETAL DISORDER 155 0.0081
794 SNEEZING 182 0.0081
795 PRODUCT DOSE OMISSION ISSUE 2386 0.0081
796 CATARACT 483 0.0081
797 DEVICE OCCLUSION 114 0.0081
798 HAEMORRHAGE INTRACRANIAL 121 0.0081
799 EYE DISORDER 266 0.0081
800 THERAPY INTERRUPTED 578 0.0081
801 INTENTIONAL DRUG MISUSE 169 0.0081
802 HEPATIC ENZYME INCREASED 549 0.0080
803 RASH 3498 0.0080
804 INJECTION SITE INDURATION 104 0.0080
805 COLITIS 304 0.0080
806 DRUG PRESCRIBING ERROR 154 0.0080
807 GASTROINTESTINAL HAEMORRHAGE 666 0.0080
808 VISUAL IMPAIRMENT 987 0.0080
809 CEREBROVASCULAR ACCIDENT 1349 0.0080
810 ANGINA PECTORIS 228 0.0079
811 PLATELET COUNT DECREASED 848 0.0079
812 RASH ERYTHEMATOUS 379 0.0079
813 HEPATIC CYTOLYSIS 101 0.0079
814 JAUNDICE 213 0.0079
815 C-REACTIVE PROTEIN INCREASED 287 0.0079
816 INTESTINAL OBSTRUCTION 297 0.0079
817 THERAPEUTIC PRODUCT EFFECT DECREASED 352 0.0079
818 COMPLICATION OF DEVICE REMOVAL 142 0.0078
819 VAGINAL HAEMORRHAGE 339 0.0078
820 TRANSAMINASES INCREASED 173 0.0078
821 SWELLING 726 0.0077
822 THERAPEUTIC RESPONSE SHORTENED 257 0.0077
823 METASTASES TO BONE 127 0.0077
824 ACUTE MYOCARDIAL INFARCTION 227 0.0077
825 PARALYSIS 110 0.0077
826 ARTHROPATHY 427 0.0077
827 ANKYLOSING SPONDYLITIS 101 0.0077
828 AGEUSIA 191 0.0076
829 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1375 0.0076
830 PANCYTOPENIA 426 0.0076
831 EXPOSURE DURING PREGNANCY 472 0.0076
832 BLOOD CREATININE INCREASED 495 0.0076
833 TOOTH LOSS 157 0.0076
834 RESPIRATORY DISORDER 226 0.0075
835 KNEE ARTHROPLASTY 159 0.0075
836 APHONIA 105 0.0075
837 PSORIATIC ARTHROPATHY 304 0.0075
838 LOCAL SWELLING 130 0.0074
839 INFECTION 1077 0.0074
840 RASH GENERALISED 191 0.0074
841 THERAPY PARTIAL RESPONDER 115 0.0074
842 BLISTER 414 0.0074
843 RASH PAPULAR 165 0.0074
844 PREMATURE DELIVERY 117 0.0073
845 HIP ARTHROPLASTY 112 0.0073
846 JOINT SWELLING 881 0.0073
847 FACE OEDEMA 123 0.0073
848 DRUG EFFECT LESS THAN EXPECTED 108 0.0073
849 PHARMACEUTICAL PRODUCT COMPLAINT 189 0.0073
850 OFF LABEL USE 6370 0.0073
851 METRORRHAGIA 124 0.0073
852 ERUCTATION 139 0.0072
853 TOXIC EPIDERMAL NECROLYSIS 109 0.0072
854 DRUG EFFECT DECREASED 385 0.0071
855 CHROMATURIA 161 0.0071
856 LACRIMATION INCREASED 214 0.0071
857 SKIN DISCOLOURATION 325 0.0071
858 FEMUR FRACTURE 218 0.0070
859 FLUID OVERLOAD 102 0.0070
860 SKIN EXFOLIATION 591 0.0070
861 DRUG DISPENSING ERROR 107 0.0070
862 DRUG INEFFECTIVE 9226 0.0070
863 PROTEINURIA 132 0.0069
864 LEUKOPENIA 347 0.0069
865 RENAL DISORDER 323 0.0069
866 GLOSSODYNIA 155 0.0069
867 MATERNAL EXPOSURE DURING PREGNANCY 617 0.0069
868 PSORIASIS 904 0.0069
869 DERMATITIS 145 0.0069
870 INJECTION SITE REACTION 475 0.0069
871 CONJUNCTIVITIS 128 0.0069
872 INJECTION SITE PRURITUS 462 0.0069
873 INJECTION SITE MASS 255 0.0069
874 INJECTION SITE URTICARIA 169 0.0069
875 DRUG DOSE OMISSION 1138 0.0069
876 MULTIPLE FRACTURES 113 0.0069
877 NEUTROPHIL COUNT DECREASED 280 0.0069
878 URTICARIA 1145 0.0068
879 INTENTIONAL PRODUCT MISUSE 598 0.0068
880 LUNG INFECTION 106 0.0068
881 EYE PRURITUS 228 0.0068
882 THERAPEUTIC RESPONSE DECREASED 411 0.0068
883 EYE IRRITATION 387 0.0067
884 HEPATITIS 172 0.0067
885 INFLAMMATION 342 0.0066
886 ANAPHYLACTIC REACTION 366 0.0066
887 STEVENS-JOHNSON SYNDROME 147 0.0066
888 LABORATORY TEST ABNORMAL 195 0.0066
889 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 468 0.0066
890 PNEUMONITIS 179 0.0066
891 METASTASES TO LIVER 115 0.0065
892 HEPATIC FAILURE 197 0.0065
893 CARDIAC DISORDER 609 0.0065
894 TREATMENT FAILURE 539 0.0065
895 HYPOACUSIS 280 0.0065
896 VISUAL ACUITY REDUCED 216 0.0065
897 ABORTION SPONTANEOUS 259 0.0065
898 BLOOD GLUCOSE DECREASED 310 0.0064
899 EOSINOPHILIA 112 0.0064
900 CEREBRAL INFARCTION 156 0.0064
901 LIVER INJURY 156 0.0063
902 LIVER DISORDER 279 0.0063
903 THROMBOCYTOPENIA 703 0.0063
904 COMPLICATION OF DEVICE INSERTION 125 0.0063
905 ILL-DEFINED DISORDER 381 0.0063
906 DRY SKIN 823 0.0062
907 RENAL IMPAIRMENT 517 0.0061
908 MUCOSAL INFLAMMATION 161 0.0061
909 INJECTION SITE BRUISING 490 0.0061
910 UNDERDOSE 447 0.0061
911 ERYTHEMA 1251 0.0061
912 DRUG EFFECT INCOMPLETE 221 0.0061
913 INFUSION RELATED REACTION 403 0.0061
914 RHEUMATOID ARTHRITIS 690 0.0061
915 FRACTURE 115 0.0061
916 ACUTE RESPIRATORY DISTRESS SYNDROME 107 0.0060
917 PRODUCT USE ISSUE 1134 0.0060
918 LACTIC ACIDOSIS 193 0.0060
919 SEPTIC SHOCK 258 0.0059
920 OSTEONECROSIS OF JAW 146 0.0059
921 DRUG-INDUCED LIVER INJURY 183 0.0058
922 LIP SWELLING 194 0.0058
923 DRUG ADMINISTRATION ERROR 178 0.0058
924 OCULAR HYPERAEMIA 273 0.0057
925 DEVICE BREAKAGE 232 0.0057
926 RASH MACULO-PAPULAR 127 0.0057
927 HAEMORRHAGE 596 0.0057
928 FEBRILE NEUTROPENIA 378 0.0057
929 APPLICATION SITE PRURITUS 129 0.0057
930 HOSPITALISATION 871 0.0057
931 LOWER RESPIRATORY TRACT INFECTION 257 0.0056
932 PAIN OF SKIN 152 0.0056
933 INJECTION SITE ERYTHEMA 696 0.0056
934 BLOOD GLUCOSE INCREASED 1056 0.0056
935 GLYCOSYLATED HAEMOGLOBIN INCREASED 139 0.0055
936 PRODUCT PHYSICAL ISSUE 111 0.0055
937 CARDIAC FAILURE 441 0.0055
938 SKIN CANCER 118 0.0055
939 BLOOD GLUCOSE ABNORMAL 101 0.0055
940 PRODUCT DISPENSING ERROR 119 0.0055
941 MENSTRUATION IRREGULAR 145 0.0054
942 MYOCARDIAL INFARCTION 944 0.0054
943 MULTIPLE ORGAN DYSFUNCTION SYNDROME 153 0.0054
944 DISEASE PROGRESSION 637 0.0054
945 APPLICATION SITE ERYTHEMA 141 0.0054
946 INJECTION SITE SWELLING 410 0.0053
947 NEUTROPENIA 720 0.0053
948 INJECTION SITE RASH 162 0.0053
949 PRODUCT QUALITY ISSUE 702 0.0052
950 CONTRAINDICATED PRODUCT ADMINISTERED 156 0.0051
951 INJECTION SITE PAIN 1571 0.0051
952 DEVICE ISSUE 458 0.0051
953 INJECTION SITE WARMTH 105 0.0051
954 PLASMA CELL MYELOMA 198 0.0051
955 DEVICE MALFUNCTION 355 0.0050
956 CARDIOVASCULAR DISORDER 128 0.0050
957 INCORRECT DOSE ADMINISTERED 1142 0.0050
958 ADVERSE EVENT 457 0.0050
959 PERITONITIS 102 0.0049
960 PRODUCT PRESCRIBING ISSUE 106 0.0049
961 NEEDLE ISSUE 139 0.0048
962 NEOPLASM PROGRESSION 166 0.0048
963 HEPATOTOXICITY 106 0.0048
964 GYNAECOMASTIA 143 0.0046
965 ACNE 349 0.0046
966 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 918 0.0045
967 DEVICE EXPULSION 276 0.0043
968 SKIN BURNING SENSATION 299 0.0042
969 EXPOSURE VIA SKIN CONTACT 108 0.0042
970 INTERSTITIAL LUNG DISEASE 201 0.0041
971 BONE DENSITY DECREASED 130 0.0041
972 INJECTION SITE HAEMORRHAGE 328 0.0041
973 MALIGNANT NEOPLASM PROGRESSION 418 0.0041
974 EXTRA DOSE ADMINISTERED 165 0.0041
975 INCORRECT DRUG ADMINISTRATION DURATION 113 0.0040
976 ANAPHYLACTIC SHOCK 102 0.0040
977 EXPIRED PRODUCT ADMINISTERED 130 0.0039
978 DEATH 3316 0.0038
979 OSTEONECROSIS 126 0.0038
980 PRODUCT ADHESION ISSUE 136 0.0038
981 HEPATIC FUNCTION ABNORMAL 136 0.0036
982 NEOPLASM MALIGNANT 234 0.0035
983 SKIN IRRITATION 160 0.0035
984 DRUG DEPENDENCE 542 0.0034
985 LUNG NEOPLASM MALIGNANT 135 0.0033
986 BREAST CANCER 299 0.0032
987 DEVICE LEAKAGE 132 0.0030
988 NO ADVERSE EVENT 518 0.0029
989 ACCIDENTAL EXPOSURE TO PRODUCT 279 0.0027
990 PROSTATE CANCER 124 0.0015
991 PRODUCT STORAGE ERROR 132 0.0015
992 DRUG DOSE OMISSION BY DEVICE 117 0.0015